title: Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults.
abstract: This paper described the Guideline for Diagnosis and Management of Hyperlipidemias for Prevention of Atherosclerosis proposed by The Japan Atherosclerosis Society (JAS) Guideline Investigating Committee (1,995-2,000) under the auspices of the JAS Board of Directors. 1) The guideline defines the diagnostic criteria for serum total cholesterol (Table 1), LDL-cholesterol (Table 1), triglycerides (Table 4) and HDL-cholesterol (Table 7). It also indicates the desirable range (Table 1), the initiation levels of management (Table 2) and the target levels of treatment (Table 2) for total and LDL-cholesterol. 2) Though both total and LDL-cholesterol are shown as atherogenic parameter in the guideline, the use of LDL-cholesterol, rather than total cholesterol, is encouraged in daily medical practice and lipid-related studies, because LDL-cholesterol is more closely related to atherosclerosis. 3) Elevated triglycerides and low HDL-cholesterol are included in the risk factors, since no sufficient data have been accumulated to formulate the guideline for these two lipid disorders. 4) Emphasis is laid on evaluation of risk factors of each subject before starting any kind of treatment (Table 2). 5) This guideline is applied solely for adults (age 20-64). Lipid abnormalities in children or the youth under age 19, and the elderly with an age over 65 have to be evaluated by their own standard. 6) This part of the guideline gives only the diagnostic aspects of hyperlipidemias. The part of management and treatment will follow in the second section of the guideline that will be published in future.
authors.forename: Yoshiya
authors.initials: Y
authors.lastname: Hata
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Mabuchi
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Saito
authors.forename: Hiroshige
authors.initials: H
authors.lastname: Itakura
authors.forename: Genshi
authors.initials: G
authors.lastname: Egusa
authors.forename: Hideki
authors.initials: H
authors.lastname: Ito
authors.forename: Tamio
authors.initials: T
authors.lastname: Teramoto
authors.forename: Motoo
authors.initials: M
authors.lastname: Tsushima
authors.forename: Norio
authors.initials: N
authors.lastname: Tada
authors.forename: Shinichi
authors.initials: S
authors.lastname: Oikawa
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Yamada
authors.forename: Shizuya
authors.initials: S
authors.lastname: Yamashita
authors.forename: Nagahiko
authors.initials: N
authors.lastname: Sakuma
authors.forename: Jun
authors.initials: J
authors.lastname: Sasaki
mesh_terms: D000328:Adult; D003327:Coronary Disease / Q000517:prevention & control; D006801:Humans; D006949:Hyperlipidemias / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D012307:Risk Factors; D012955:Societies, Medical